Home › Funds › Soleus Capital Management, L.P. › INDV

Soleus Capital Management, L.P. position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Soleus Capital Management, L.P. reported holding 1,064,000 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$43.7M, representing 1.50% of its reported portfolio and ranking #18 among its reported holdings. Soleus Capital Management, L.P. has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.06M sh
Reported value held$43.66M
Portfolio Weight1.50%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s INDV position evolved

Soleus Capital Management, L.P. first disclosed a stake in INDV in Q3 2025 at 1,466,000 shares (US$35.3M). The position peaked in Q2 2026 at 1,064,000 shares, worth US$43.7M. Across 4 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,064,000 shares valued at US$43.7M — a reduction of -210,000 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2025 (shares fell 15% over the following quarter), a 1174% increase in Q1 2026 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.47M $35.35M New
Q4 2025 100.00K $3.59M Reduce
Q1 2026 1.27M $38.83M Add
Q2 2026 1.06M $43.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Soleus Capital Management, L.P. held INDV?

Soleus Capital Management, L.P. has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Soleus Capital Management, L.P.'s current position in INDV?

As of Q2 2026, Soleus Capital Management, L.P. holds 1.06M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $43.66M, representing 1.50% of its reported portfolio and ranking #18.

Has Soleus Capital Management, L.P. been buying or selling INDV?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in INDV. The position peaked in Q2 2026 at 1.06M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.